메뉴 건너뛰기




Volumn 7, Issue 10, 2012, Pages

Neutrophil Gelatinase-Associated Lipocalin (NGAL) Predicts Response to Neoadjuvant Chemotherapy and Clinical Outcome in Primary Human Breast Cancer

Author keywords

[No Author keywords available]

Indexed keywords

CAPECITABINE; CYCLOPHOSPHAMIDE; DOCETAXEL; DOXORUBICIN; EPIDERMAL GROWTH FACTOR RECEPTOR 2; ESTROGEN RECEPTOR; HORMONE RECEPTOR; NAVELBINE; NEUTROPHIL GELATINASE ASSOCIATED LIPOCALIN; PROGESTERONE RECEPTOR;

EID: 84867311375     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0045826     Document Type: Article
Times cited : (46)

References (43)
  • 1
    • 0027256664 scopus 로고
    • Isolation and primary structure of NGAL, a novel protein associated with human neutrophil gelatinase
    • Kjeldsen L, Johnsen AH, Sengelov H, Borregaard N, (1993) Isolation and primary structure of NGAL, a novel protein associated with human neutrophil gelatinase. J Biol Chem 268: 10425-10432.
    • (1993) J Biol Chem , vol.268 , pp. 10425-10432
    • Kjeldsen, L.1    Johnsen, A.H.2    Sengelov, H.3    Borregaard, N.4
  • 2
    • 0029790266 scopus 로고    scopus 로고
    • The lipocalin protein family: structure and function
    • Flower DR, (1996) The lipocalin protein family: structure and function. Biochem J 318 (Pt 1):: 1-14.
    • (1996) Biochem J , vol.318 , Issue.Pt 1 , pp. 1-14
    • Flower, D.R.1
  • 3
    • 0034684231 scopus 로고    scopus 로고
    • Lipocalins and cancer
    • Bratt T, (2000) Lipocalins and cancer. Biochim Biophys Acta 1482: 318-326.
    • (2000) Biochim Biophys Acta , vol.1482 , pp. 318-326
    • Bratt, T.1
  • 4
    • 14844331424 scopus 로고    scopus 로고
    • Expression of neutrophil gelatinase-associated lipocalin regulates epithelial morphogenesis in vitro
    • Gwira JA, Wei F, Ishibe S, Ueland JM, Barasch J, et al. (2005) Expression of neutrophil gelatinase-associated lipocalin regulates epithelial morphogenesis in vitro. J Biol Chem 280: 7875-7882.
    • (2005) J Biol Chem , vol.280 , pp. 7875-7882
    • Gwira, J.A.1    Wei, F.2    Ishibe, S.3    Ueland, J.M.4    Barasch, J.5
  • 5
    • 41149144686 scopus 로고    scopus 로고
    • Neutrophil gelatinase-associated lipocalin (NGAL) is a predictor of poor prognosis in human primary breast cancer
    • Bauer M, Eickhoff JC, Gould MN, Mundhenke C, Maass N, et al. (2008) Neutrophil gelatinase-associated lipocalin (NGAL) is a predictor of poor prognosis in human primary breast cancer. Breast Cancer Res Treat 108: 389-397.
    • (2008) Breast Cancer Res Treat , vol.108 , pp. 389-397
    • Bauer, M.1    Eickhoff, J.C.2    Gould, M.N.3    Mundhenke, C.4    Maass, N.5
  • 6
    • 0029563573 scopus 로고
    • Overexpression of neu-related lipocalin (NRL) in neu-initiated but not ras or chemically initiated rat mammary carcinomas
    • Stoesz SP, Gould MN, (1995) Overexpression of neu-related lipocalin (NRL) in neu-initiated but not ras or chemically initiated rat mammary carcinomas. Oncogene 11: 2233-2241.
    • (1995) Oncogene , vol.11 , pp. 2233-2241
    • Stoesz, S.P.1    Gould, M.N.2
  • 7
    • 34547747873 scopus 로고    scopus 로고
    • Clinical evidence for a protective role of lipocalin-2 against MMP-9 autodegradation and the impact for gastric cancer
    • Kubben FJ, Sier CF, Hawinkels LJ, Tschesche H, van Duijn W, et al. (2007) Clinical evidence for a protective role of lipocalin-2 against MMP-9 autodegradation and the impact for gastric cancer. Eur J Cancer 43: 1869-1876.
    • (2007) Eur J Cancer , vol.43 , pp. 1869-1876
    • Kubben, F.J.1    Sier, C.F.2    Hawinkels, L.J.3    Tschesche, H.4    van Duijn, W.5
  • 8
    • 78049486436 scopus 로고    scopus 로고
    • Expressions of neutrophil gelatinase-associated lipocalin in gastric cancer: a potential biomarker for prognosis and an ancillary diagnostic test
    • Wang HJ, He XJ, Ma YY, Jiang XT, Xia YJ, et al. (2010) Expressions of neutrophil gelatinase-associated lipocalin in gastric cancer: a potential biomarker for prognosis and an ancillary diagnostic test. Anat Rec (Hoboken) 293: 1855-1863.
    • (2010) Anat Rec (Hoboken) , vol.293 , pp. 1855-1863
    • Wang, H.J.1    He, X.J.2    Ma, Y.Y.3    Jiang, X.T.4    Xia, Y.J.5
  • 9
    • 34249914771 scopus 로고    scopus 로고
    • Upregulation of neutrophil gelatinase-associated lipocalin in oesophageal squamous cell carcinoma: significant correlation with cell differentiation and tumour invasion
    • Zhang H, Xu L, Xiao D, Xie J, Zeng H, et al. (2007) Upregulation of neutrophil gelatinase-associated lipocalin in oesophageal squamous cell carcinoma: significant correlation with cell differentiation and tumour invasion. J Clin Pathol 60: 555-561.
    • (2007) J Clin Pathol , vol.60 , pp. 555-561
    • Zhang, H.1    Xu, L.2    Xiao, D.3    Xie, J.4    Zeng, H.5
  • 10
    • 77954365854 scopus 로고    scopus 로고
    • Neutrophil gelatinase-associated lipocalin immunoexpression in renal tumors: correlation with histotype and histological grade
    • Barresi V, Ieni A, Bolignano D, Magno C, Buemi M, et al. (2010) Neutrophil gelatinase-associated lipocalin immunoexpression in renal tumors: correlation with histotype and histological grade. Oncol Rep 24: 305-310.
    • (2010) Oncol Rep , vol.24 , pp. 305-310
    • Barresi, V.1    Ieni, A.2    Bolignano, D.3    Magno, C.4    Buemi, M.5
  • 11
    • 52949106096 scopus 로고    scopus 로고
    • The neutrophil gelatinase-associated lipocalin (NGAL), a NF-kappaB-regulated gene, is a survival factor for thyroid neoplastic cells
    • Iannetti A, Pacifico F, Acquaviva R, Lavorgna A, Crescenzi E, et al. (2008) The neutrophil gelatinase-associated lipocalin (NGAL), a NF-kappaB-regulated gene, is a survival factor for thyroid neoplastic cells. Proc Natl Acad Sci U S A 105: 14058-14063.
    • (2008) Proc Natl Acad Sci U S A , vol.105 , pp. 14058-14063
    • Iannetti, A.1    Pacifico, F.2    Acquaviva, R.3    Lavorgna, A.4    Crescenzi, E.5
  • 12
    • 34247359877 scopus 로고    scopus 로고
    • Neutrophil gelatinase-associated lipocalin (NGAL) an early-screening biomarker for ovarian cancer: NGAL is associated with epidermal growth factor-induced epithelio-mesenchymal transition
    • Lim R, Ahmed N, Borregaard N, Riley C, Wafai R, et al. (2007) Neutrophil gelatinase-associated lipocalin (NGAL) an early-screening biomarker for ovarian cancer: NGAL is associated with epidermal growth factor-induced epithelio-mesenchymal transition. Int J Cancer 120: 2426-2434.
    • (2007) Int J Cancer , vol.120 , pp. 2426-2434
    • Lim, R.1    Ahmed, N.2    Borregaard, N.3    Riley, C.4    Wafai, R.5
  • 13
    • 27444447914 scopus 로고    scopus 로고
    • Neutrophil gelatinase-associated lipocalin as a survival factor
    • Tong Z, Wu X, Ovcharenko D, Zhu J, Chen CS, et al. (2005) Neutrophil gelatinase-associated lipocalin as a survival factor. Biochem J 391: 441-448.
    • (2005) Biochem J , vol.391 , pp. 441-448
    • Tong, Z.1    Wu, X.2    Ovcharenko, D.3    Zhu, J.4    Chen, C.S.5
  • 14
    • 33646436461 scopus 로고    scopus 로고
    • Ectopic expression of neutrophil gelatinase-associated lipocalin suppresses the invasion and liver metastasis of colon cancer cells
    • Lee HJ, Lee EK, Lee KJ, Hong SW, Yoon Y, et al. (2006) Ectopic expression of neutrophil gelatinase-associated lipocalin suppresses the invasion and liver metastasis of colon cancer cells. Int J Cancer 118: 2490-2497.
    • (2006) Int J Cancer , vol.118 , pp. 2490-2497
    • Lee, H.J.1    Lee, E.K.2    Lee, K.J.3    Hong, S.W.4    Yoon, Y.5
  • 15
    • 80051790728 scopus 로고    scopus 로고
    • Neutrophil gelatinase-associated lipocalin: a new prognostic marker in stage I colorectal carcinoma?
    • Barresi V, Di Gregorio C, Reggiani-Bonetti L, Ieni A, Ponz-De Leon M, et al. (2011) Neutrophil gelatinase-associated lipocalin: a new prognostic marker in stage I colorectal carcinoma? Hum Pathol 42: 1720-1726.
    • (2011) Hum Pathol , vol.42 , pp. 1720-1726
    • Barresi, V.1    Di Gregorio, C.2    Reggiani-Bonetti, L.3    Ieni, A.4    Ponz-De Leon, M.5
  • 16
    • 79960314350 scopus 로고    scopus 로고
    • NGAL expression is elevated in both colorectal adenoma-carcinoma sequence and cancer progression and enhances tumorigenesis in xenograft mouse models
    • Sun Y, Yokoi K, Li H, Gao J, Hu L, et al. (2011) NGAL expression is elevated in both colorectal adenoma-carcinoma sequence and cancer progression and enhances tumorigenesis in xenograft mouse models. Clin Cancer Res 17: 4331-4340.
    • (2011) Clin Cancer Res , vol.17 , pp. 4331-4340
    • Sun, Y.1    Yokoi, K.2    Li, H.3    Gao, J.4    Hu, L.5
  • 17
    • 0031738123 scopus 로고    scopus 로고
    • Heterogeneous expression of the lipocalin NGAL in primary breast cancers
    • Stoesz SP, Friedl A, Haag JD, Lindstrom MJ, Clark GM, et al. (1998) Heterogeneous expression of the lipocalin NGAL in primary breast cancers. Int J Cancer 79: 565-572.
    • (1998) Int J Cancer , vol.79 , pp. 565-572
    • Stoesz, S.P.1    Friedl, A.2    Haag, J.D.3    Lindstrom, M.J.4    Clark, G.M.5
  • 19
    • 13244268450 scopus 로고    scopus 로고
    • 30 years' follow up of randomised studies of adjuvant CMF in operable breast cancer: cohort study
    • Bonadonna G, Moliterni A, Zambetti M, Daidone MG, Pilotti S, et al. (2005) 30 years' follow up of randomised studies of adjuvant CMF in operable breast cancer: cohort study. BMJ 330: 217.
    • (2005) BMJ , vol.330 , pp. 217
    • Bonadonna, G.1    Moliterni, A.2    Zambetti, M.3    Daidone, M.G.4    Pilotti, S.5
  • 20
    • 0035751675 scopus 로고    scopus 로고
    • Preoperative chemotherapy in patients with operable breast cancer: nine-year results from National Surgical Adjuvant Breast and Bowel Project B-18
    • Wolmark N, Wang J, Mamounas E, Bryant J, Fisher B, (2001) Preoperative chemotherapy in patients with operable breast cancer: nine-year results from National Surgical Adjuvant Breast and Bowel Project B-18. J Natl Cancer Inst Monogr pp. 96-102.
    • (2001) J Natl Cancer Inst Monogr , pp. 96-102
    • Wolmark, N.1    Wang, J.2    Mamounas, E.3    Bryant, J.4    Fisher, B.5
  • 21
    • 33749061057 scopus 로고    scopus 로고
    • Neoadjuvant treatment for early-stage breast cancer: opportunities to assess tumour response
    • Jones RL, Smith IE, (2006) Neoadjuvant treatment for early-stage breast cancer: opportunities to assess tumour response. Lancet Oncol 7: 869-874.
    • (2006) Lancet Oncol , vol.7 , pp. 869-874
    • Jones, R.L.1    Smith, I.E.2
  • 22
    • 0031926839 scopus 로고    scopus 로고
    • Effect of preoperative chemotherapy on the outcome of women with operable breast cancer
    • Fisher B, Bryant J, Wolmark N, Mamounas E, Brown A, et al. (1998) Effect of preoperative chemotherapy on the outcome of women with operable breast cancer. J Clin Oncol 16: 2672-2685.
    • (1998) J Clin Oncol , vol.16 , pp. 2672-2685
    • Fisher, B.1    Bryant, J.2    Wolmark, N.3    Mamounas, E.4    Brown, A.5
  • 23
    • 33646445341 scopus 로고    scopus 로고
    • Sequential preoperative or postoperative docetaxel added to preoperative doxorubicin plus cyclophosphamide for operable breast cancer:National Surgical Adjuvant Breast and Bowel Project Protocol B-27
    • Bear HD, Anderson S, Smith RE, Geyer CE Jr, Mamounas EP, et al. (2006) Sequential preoperative or postoperative docetaxel added to preoperative doxorubicin plus cyclophosphamide for operable breast cancer:National Surgical Adjuvant Breast and Bowel Project Protocol B-27. J Clin Oncol 24: 2019-2027.
    • (2006) J Clin Oncol , vol.24 , pp. 2019-2027
    • Bear, H.D.1    Anderson, S.2    Smith, R.E.3    Geyer Jr., C.E.4    Mamounas, E.P.5
  • 24
    • 33947207819 scopus 로고    scopus 로고
    • HER-2, p53, p21 and hormonal receptors proteins expression as predictive factors of response and prognosis in locally advanced breast cancer treated with neoadjuvant docetaxel plus epirubicin combination
    • Tiezzi DG, Andrade JM, Ribeiro-Silva A, Zola FE, Marana HR, et al. (2007) HER-2, p53, p21 and hormonal receptors proteins expression as predictive factors of response and prognosis in locally advanced breast cancer treated with neoadjuvant docetaxel plus epirubicin combination. BMC Cancer 7: 36.
    • (2007) BMC Cancer , vol.7 , pp. 36
    • Tiezzi, D.G.1    Andrade, J.M.2    Ribeiro-Silva, A.3    Zola, F.E.4    Marana, H.R.5
  • 25
    • 33745609547 scopus 로고    scopus 로고
    • Primary systemic therapy in operable breast cancer: clinical data and biological fall-out
    • Maur M, Guarneri V, Frassoldati A, Conte PF, (2006) Primary systemic therapy in operable breast cancer: clinical data and biological fall-out. Ann Oncol 17 Suppl 5: v158-164.
    • (2006) Ann Oncol , vol.17 , Issue.SUPPL. 5
    • Maur, M.1    Guarneri, V.2    Frassoldati, A.3    Conte, P.F.4
  • 26
    • 33646885250 scopus 로고    scopus 로고
    • Clinical and pathological predictors of the response to neoadjuvant anthracycline chemotherapy in locally advanced breast cancer
    • Fernandez-Sanchez M, Gamboa-Dominguez A, Uribe N, Garcia-Ulloa AC, Flores-Estrada D, et al. (2006) Clinical and pathological predictors of the response to neoadjuvant anthracycline chemotherapy in locally advanced breast cancer. Med Oncol 23: 171-183.
    • (2006) Med Oncol , vol.23 , pp. 171-183
    • Fernandez-Sanchez, M.1    Gamboa-Dominguez, A.2    Uribe, N.3    Garcia-Ulloa, A.C.4    Flores-Estrada, D.5
  • 27
    • 1642473193 scopus 로고    scopus 로고
    • The poor responsiveness of infiltrating lobular breast carcinomas to neoadjuvant chemotherapy can be explained by their biological profile
    • Mathieu MC, Rouzier R, Llombart-Cussac A, Sideris L, Koscielny S, et al. (2004) The poor responsiveness of infiltrating lobular breast carcinomas to neoadjuvant chemotherapy can be explained by their biological profile. Eur J Cancer 40: 342-351.
    • (2004) Eur J Cancer , vol.40 , pp. 342-351
    • Mathieu, M.C.1    Rouzier, R.2    Llombart-Cussac, A.3    Sideris, L.4    Koscielny, S.5
  • 28
    • 23844549918 scopus 로고    scopus 로고
    • Breast cancer molecular subtypes respond differently to preoperative chemotherapy
    • Rouzier R, Perou CM, Symmans WF, Ibrahim N, Cristofanilli M, et al. (2005) Breast cancer molecular subtypes respond differently to preoperative chemotherapy. Clin Cancer Res 11: 5678-5685.
    • (2005) Clin Cancer Res , vol.11 , pp. 5678-5685
    • Rouzier, R.1    Perou, C.M.2    Symmans, W.F.3    Ibrahim, N.4    Cristofanilli, M.5
  • 29
    • 28044472321 scopus 로고    scopus 로고
    • Gene expression profiles in paraffin-embedded core biopsy tissue predict response to chemotherapy in women with locally advanced breast cancer
    • Gianni L, Zambetti M, Clark K, Baker J, Cronin M, et al. (2005) Gene expression profiles in paraffin-embedded core biopsy tissue predict response to chemotherapy in women with locally advanced breast cancer. J Clin Oncol 23: 7265-7277.
    • (2005) J Clin Oncol , vol.23 , pp. 7265-7277
    • Gianni, L.1    Zambetti, M.2    Clark, K.3    Baker, J.4    Cronin, M.5
  • 30
    • 33646339959 scopus 로고    scopus 로고
    • Gene expression signature predicting pathologic complete response with gemcitabine, epirubicin, and docetaxel in primary breast cancer
    • Thuerigen O, Schneeweiss A, Toedt G, Warnat P, Hahn M, et al. (2006) Gene expression signature predicting pathologic complete response with gemcitabine, epirubicin, and docetaxel in primary breast cancer. J Clin Oncol 24: 1839-1845.
    • (2006) J Clin Oncol , vol.24 , pp. 1839-1845
    • Thuerigen, O.1    Schneeweiss, A.2    Toedt, G.3    Warnat, P.4    Hahn, M.5
  • 31
    • 33749030177 scopus 로고    scopus 로고
    • Pharmacogenomic predictor of sensitivity to preoperative chemotherapy with paclitaxel and fluorouracil, doxorubicin, and cyclophosphamide in breast cancer
    • Hess KR, Anderson K, Symmans WF, Valero V, Ibrahim N, et al. (2006) Pharmacogenomic predictor of sensitivity to preoperative chemotherapy with paclitaxel and fluorouracil, doxorubicin, and cyclophosphamide in breast cancer. J Clin Oncol 24: 4236-4244.
    • (2006) J Clin Oncol , vol.24 , pp. 4236-4244
    • Hess, K.R.1    Anderson, K.2    Symmans, W.F.3    Valero, V.4    Ibrahim, N.5
  • 32
    • 43149114454 scopus 로고    scopus 로고
    • Intensified neoadjuvant chemotherapy in early-responding breast cancer: phase III randomized GeparTrio study
    • von Minckwitz G, Kummel S, Vogel P, Hanusch C, Eidtmann H, et al. (2008) Intensified neoadjuvant chemotherapy in early-responding breast cancer: phase III randomized GeparTrio study. J Natl Cancer Inst 100: 552-562.
    • (2008) J Natl Cancer Inst , vol.100 , pp. 552-562
    • von Minckwitz, G.1    Kummel, S.2    Vogel, P.3    Hanusch, C.4    Eidtmann, H.5
  • 33
    • 43149120682 scopus 로고    scopus 로고
    • Neoadjuvant vinorelbine-capecitabine versus docetaxel-doxorubicin-cyclophosphamide in early nonresponsive breast cancer: phase III randomized GeparTrio trial
    • von Minckwitz G, Kummel S, Vogel P, Hanusch C, Eidtmann H, et al. (2008) Neoadjuvant vinorelbine-capecitabine versus docetaxel-doxorubicin-cyclophosphamide in early nonresponsive breast cancer: phase III randomized GeparTrio trial. J Natl Cancer Inst 100: 542-551.
    • (2008) J Natl Cancer Inst , vol.100 , pp. 542-551
    • von Minckwitz, G.1    Kummel, S.2    Vogel, P.3    Hanusch, C.4    Eidtmann, H.5
  • 34
    • 77957710541 scopus 로고    scopus 로고
    • Effect of neoadjuvant anthracycline-taxane-based chemotherapy in different biological breast cancer phenotypes: overall results from the GeparTrio study
    • Huober J, von Minckwitz G, Denkert C, Tesch H, Weiss E, et al. (2010) Effect of neoadjuvant anthracycline-taxane-based chemotherapy in different biological breast cancer phenotypes: overall results from the GeparTrio study. Breast Cancer Res Treat 124: 133-140.
    • (2010) Breast Cancer Res Treat , vol.124 , pp. 133-140
    • Huober, J.1    von Minckwitz, G.2    Denkert, C.3    Tesch, H.4    Weiss, E.5
  • 35
    • 0032896905 scopus 로고    scopus 로고
    • Estrogen receptor status by immunohistochemistry is superior to the ligand-binding assay for predicting response to adjuvant endocrine therapy in breast cancer
    • Harvey JM, Clark GM, Osborne CK, Allred DC, (1999) Estrogen receptor status by immunohistochemistry is superior to the ligand-binding assay for predicting response to adjuvant endocrine therapy in breast cancer. J Clin Oncol 17: 1474-1481.
    • (1999) J Clin Oncol , vol.17 , pp. 1474-1481
    • Harvey, J.M.1    Clark, G.M.2    Osborne, C.K.3    Allred, D.C.4
  • 36
    • 0032799411 scopus 로고    scopus 로고
    • Neutrophil gelatinase-associated lipocalin in normal and neoplastic human tissues. Cell type-specific pattern of expression
    • Friedl A, Stoesz SP, Buckley P, Gould MN, (1999) Neutrophil gelatinase-associated lipocalin in normal and neoplastic human tissues. Cell type-specific pattern of expression. Histochem J 31: 433-441.
    • (1999) Histochem J , vol.31 , pp. 433-441
    • Friedl, A.1    Stoesz, S.P.2    Buckley, P.3    Gould, M.N.4
  • 37
    • 13844310310 scopus 로고    scopus 로고
    • Gene-expression profiles to predict distant metastasis of lymph-node-negative primary breast cancer
    • Wang Y, Klijn JG, Zhang Y, Sieuwerts AM, Look MP, et al. (2005) Gene-expression profiles to predict distant metastasis of lymph-node-negative primary breast cancer. Lancet 365: 671-679.
    • (2005) Lancet , vol.365 , pp. 671-679
    • Wang, Y.1    Klijn, J.G.2    Zhang, Y.3    Sieuwerts, A.M.4    Look, M.P.5
  • 38
    • 0037137519 scopus 로고    scopus 로고
    • A gene-expression signature as a predictor of survival in breast cancer
    • van de Vijver MJ, He YD, van't Veer LJ, Dai H, Hart AA, et al. (2002) A gene-expression signature as a predictor of survival in breast cancer. N Engl J Med 347: 1999-2009.
    • (2002) N Engl J Med , vol.347 , pp. 1999-2009
    • van de Vijver, M.J.1    He, Y.D.2    van't Veer, L.J.3    Dai, H.4    Hart, A.A.5
  • 39
    • 53049100145 scopus 로고    scopus 로고
    • Predictive markers of response to neoadjuvant chemotherapy in breast cancer
    • Tewari M, Krishnamurthy A, Shukla HS, (2008) Predictive markers of response to neoadjuvant chemotherapy in breast cancer. Surg Oncol 17: 301-311.
    • (2008) Surg Oncol , vol.17 , pp. 301-311
    • Tewari, M.1    Krishnamurthy, A.2    Shukla, H.S.3
  • 40
    • 79957940705 scopus 로고    scopus 로고
    • Cytoplasmic poly(adenosine diphosphate-ribose) polymerase expression is predictive and prognostic in patients with breast cancer treated with neoadjuvant chemotherapy
    • von Minckwitz G, Muller BM, Loibl S, Budczies J, Hanusch C, et al. (2011) Cytoplasmic poly(adenosine diphosphate-ribose) polymerase expression is predictive and prognostic in patients with breast cancer treated with neoadjuvant chemotherapy. J Clin Oncol 29: 2150-2157.
    • (2011) J Clin Oncol , vol.29 , pp. 2150-2157
    • von Minckwitz, G.1    Muller, B.M.2    Loibl, S.3    Budczies, J.4    Hanusch, C.5
  • 41
    • 67650349829 scopus 로고    scopus 로고
    • Recent advances in systemic therapy: new diagnostics and biological predictors of outcome in early breast cancer
    • Oakman C, Bessi S, Zafarana E, Galardi F, Biganzoli L, et al. (2009) Recent advances in systemic therapy: new diagnostics and biological predictors of outcome in early breast cancer. Breast Cancer Res 11: 205.
    • (2009) Breast Cancer Res , vol.11 , pp. 205
    • Oakman, C.1    Bessi, S.2    Zafarana, E.3    Galardi, F.4    Biganzoli, L.5
  • 42
    • 73649135741 scopus 로고    scopus 로고
    • Neutrophil gelatinase-associated lipocalin (NGAL) in human neoplasias: a new protein enters the scene
    • Bolignano D, Donato V, Lacquaniti A, Fazio MR, Bono C, et al. (2010) Neutrophil gelatinase-associated lipocalin (NGAL) in human neoplasias: a new protein enters the scene. Cancer Lett 288: 10-16.
    • (2010) Cancer Lett , vol.288 , pp. 10-16
    • Bolignano, D.1    Donato, V.2    Lacquaniti, A.3    Fazio, M.R.4    Bono, C.5
  • 43
    • 23044499535 scopus 로고    scopus 로고
    • The matrix metalloproteinase-9/neutrophil gelatinase-associated lipocalin complex plays a role in breast tumor growth and is present in the urine of breast cancer patients
    • Fernandez CA, Yan L, Louis G, Yang J, Kutok JL, et al. (2005) The matrix metalloproteinase-9/neutrophil gelatinase-associated lipocalin complex plays a role in breast tumor growth and is present in the urine of breast cancer patients. Clin Cancer Res 11: 5390-5395.
    • (2005) Clin Cancer Res , vol.11 , pp. 5390-5395
    • Fernandez, C.A.1    Yan, L.2    Louis, G.3    Yang, J.4    Kutok, J.L.5


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.